{"denomUnitsSelected":"Participants","description":"Measured in months between the date of enrollment and the first efficacy evaluation at which the participant has met the criteria for Progressive Disease","reportingStatus":"NOT_POSTED","timeFrame":"Approximately 3 years","title":"Time to Progression","type":"SECONDARY"}